|
Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2019-12-01
Est. completion2021-07-01
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT03775031
Summary
The purpose of this study is to evaluate the impact of fractional laser versus chemical peels on IGF-1 levels in skin.
Eligibility
Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria: * Male and female subjects \>55 years old * Fitzpatrick type I-II * Able to provide informed consent. * Cutaneous photodamage of 3 or above on the Larnier photodamage scale (see Appendix). Exclusion Criteria: * Prior laser or peel treatment in the area evaluated in the current study in the past year. * Currently taking immunosuppressant medications known to interfere wound healing or anti-inflammatory medications (such as NSAIDs, or steroids). * Subjects who have underlying diseases that could alter wound healing response (such as Diabetes). * Currently taking insulin. * History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study. * History of abnormal scarring such as Keloids. * History of vitiligo. * Allergy or sensitivity or allergy to topical anesthesia * Inability to use sunscreen. * History of smoking in the last 10 years * Scar or prior surgery in the area of treatment. * Use of isotretinoin in the prior 6 months * Subjects who have bleeding disorders or who are taking anticoagulants
Conditions2
CancerSkin Cancer
Locations1 site
Massachusetts General Hospital Clinical Unit for Research Trials and Outcomes in Skin
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2019-12-01
Est. completion2021-07-01
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT03775031